These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Functional and Cognitive Improvement After an Intensive Inpatient Multidisciplinary Rehabilitation Program in Mild to Severe Parkinson's Disease: A Retrospective and Observational Study. Meloni M; Saibene FL; Di Tella S; Di Cesare M; Borgnis F; Nemni R; Baglio F Front Neurol; 2021; 12():626041. PubMed ID: 33815253 [TBL] [Abstract][Full Text] [Related]
9. Frequency of Cognitive Impairment in Patients with Parkinson's Disease. Taimur M; Shah MAA; Ali M; Barry HD; Hussain SZM; Shahzad H; Rizwan A Cureus; 2019 May; 11(5):e4733. PubMed ID: 31355092 [TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of Motor Dysfunction in Parkinson's Disease as the Rationale for Drug Treatment and Rehabilitation. Magrinelli F; Picelli A; Tocco P; Federico A; Roncari L; Smania N; Zanette G; Tamburin S Parkinsons Dis; 2016; 2016():9832839. PubMed ID: 27366343 [TBL] [Abstract][Full Text] [Related]
12. Nonmotor symptoms in essential tremor: Comparison with Parkinson's disease and normal control. Lee SM; Kim M; Lee HM; Kwon KY; Koh SB J Neurol Sci; 2015 Feb; 349(1-2):168-73. PubMed ID: 25641389 [TBL] [Abstract][Full Text] [Related]
13. Overview of Parkinson's disease. Lew M Pharmacotherapy; 2007 Dec; 27(12 Pt 2):155S-160S. PubMed ID: 18041935 [TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease and Parkinson's disease psychosis: a perspective on the challenges, treatments, and economic burden. Fredericks D; Norton JC; Atchison C; Schoenhaus R; Pill MW Am J Manag Care; 2017 Apr; 23(5 Suppl):S83-S92. PubMed ID: 28715903 [TBL] [Abstract][Full Text] [Related]
15. Cognitive and behavioral disorders in Parkinson's disease: an update. I: cognitive impairments. Papagno C; Trojano L Neurol Sci; 2018 Feb; 39(2):215-223. PubMed ID: 29043468 [TBL] [Abstract][Full Text] [Related]